1. Home
  2. HROW vs SDGR Comparison

HROW vs SDGR Comparison

Compare HROW & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$40.64

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

HOLD

Current Price

$13.70

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HROW
SDGR
Founded
1998
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
HROW
SDGR
Price
$40.64
$13.70
Analyst Decision
Strong Buy
Buy
Analyst Count
8
9
Target Price
$68.86
$24.33
AVG Volume (30 Days)
579.2K
1.2M
Earning Date
03-16-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$250,042,000.00
$256,951,000.00
Revenue This Year
$38.57
$23.69
Revenue Next Year
$42.17
$20.32
P/E Ratio
N/A
N/A
Revenue Growth
47.83
32.90
52 Week Low
$20.85
$13.44
52 Week High
$54.85
$28.47

Technical Indicators

Market Signals
Indicator
HROW
SDGR
Relative Strength Index (RSI) 31.23 24.15
Support Level $44.55 $16.07
Resistance Level $44.05 $17.87
Average True Range (ATR) 2.08 0.76
MACD -0.96 -0.40
Stochastic Oscillator 1.26 3.88

Price Performance

Historical Comparison
HROW
SDGR

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Share on Social Networks: